Celiva Logo

Revolutionizing Celiac Disease Screening

A simple, non-invasive saliva test that makes screening accessible and affordable for everyone.

Key Features

Non-invasive saliva test

Simple and painless collection method

Affordable at just $25

Making testing accessible for everyone

Multiple biomarkers

Enhanced accuracy through comprehensive testing

Results in minutes

No more waiting for months

Celiac Disease: A Growing Epidemic

Current diagnosis methods are complex, costly, and slow, leading to years of unnecessary suffering.

Global Impact

112M+

People affected globally, including 400,000 Australians

Delayed Diagnosis

6-10

Years average time until proper diagnosis

Complex Symptoms

4+

Major symptoms including fatigue, anemia, IBS, depression

High Costs

$475

Maximum cost for current testing methods

Latest Updates

Stay updated with our latest achievements and milestones as we work towards making Celiac disease screening more accessible.

MedTech Actuator Demo Day

October 30, 2025

Join us on October 30 at Work Club Olderfleet in Melbourne as we pitch at the MedTech Actuator Accelerator Australia Demo Day! We're showcasing how Celiva is tackling one of healthcare's biggest challenges with our non-invasive celiac disease screening solution. The event features groundbreaking Australian healthtech startups working on everything from personalised disease management to next-generation therapeutics. Spaces are limited!

Meet Our Team: Biotech Experts

Our diverse team combines expertise in biotechnology, medicine, computer science, and business to revolutionize Celiac disease screening.

Tahra Allen

Tahra Allen

Business Strategy & Development

Khiem Nguyen

Khiem Nguyen

Biotech Strategy & Communications

Pranav Kataria

Pranav Kataria

Software & Research

Avi Jayaprabalan

Avi Jayaprabalan

Scientific Research